PATENT CLAIM ANALYSIS

Application Number: 16087947
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["546", "053000"]

Abstract:
The present invention provides a medicament useful for treatment and/or prevention of cancer, a vaccine adjuvant, and an inhibitor of immune checkpoint comprising a compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein Bonds a-d, Ring A, R 1 , R 1′ , R 2 , R 2′ , R 3 -R 8 , and n are as defined in the present specification.

Claim (Index 7):
The compound of  claim 1  or a pharmaceutical acceptable salt thereof, wherein Ring A is C 5-6  cycloalkyl ring, C 5-6  cycloalkenyl ring, or 5- or 6-membered saturated monocyclic heterocycle, wherein the cycloalkyl ring, cycloalkenyl ring, and saturated monocyclic heterocycle may be independently substituted with one or more the same or different groups selected from the group consisting of hydroxy, oxo, C 1-6  alkyl, C 1-6  haloalkyl, C 1-6  hydroxyalkyl, C 1-6  alkoxy, and C 1-6  haloalkoxy, at any substitutable position.

Metadata:
- Claim Count in Document: 36.0
- Percentile: 97.0
- Lexical Diversity: 1.37037
- Patent Class: 546.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15766985', '14238507', '10932463', '11587906', '15799771']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7989059216090132
- 35 USC 102 Novelty (BERT): 0.5219013359659932
- Combined Prediction Score: 0.7712054630447112
- Mean Citation Score: 319.059382
- Max Citation Score: 326.9722
- Similarity Product: 252.13264343853

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test